| Market Capitalization (Millions $) |
625 |
| Shares
Outstanding (Millions) |
31 |
| Employees |
1,344 |
| Revenues (TTM) (Millions $) |
319 |
| Net Income (TTM) (Millions $) |
-75 |
| Cash Flow (TTM) (Millions $) |
-44 |
| Capital Exp. (TTM) (Millions $) |
23 |
Business Description
Fulgent Genetics Inc. is a technology-based genetic testing company that offers a range of genetic testing solutions to medical professionals, researchers, and patients. It focuses on providing genetic testing services for various cancer-related and genetic diseases.
Founded in 2011 and based in Temple City, California, Fulgent Genetics Inc. offers a wide range of next-generation sequencing (NGS) and microarray products and services. These include genetic testing panels, whole-exome sequencing, carrier screening, prenatal testing, and pharmacogenetics testing.
The company's mission is to improve patient outcomes by providing high-quality, affordable genetic testing solutions that enable clinicians and researchers to make better-informed decisions for their patients. Its approach is characterized by a focus on quality, speed, and affordability of its testing services.
Fulgent Genetics Inc.'s technology platform is based on its proprietary CAP-accredited and CLIA-certified technology which has enabled the company to rapidly scale its genetic testing capabilities. It has also enabled the company to deliver accurate and reliable results at lower prices than many of its competitors.
The company's comprehensive genetic testing portfolio includes its flagship FulgentOnee Suite of Tests, which includes more than 18,000 genes in its clinical diagnostic exome sequencing tests. This suite of tests is designed to provide physicians with a variety of options to choose from, depending on their patients' specific needs.
Fulgent Genetics Inc. has built a vast network of more than 10,000 US-based clinicians and researchers who rely on its genetic testing services. The company also has partnerships with several major healthcare providers and pharmaceutical companies.
In recent years, Fulgent Genetics Inc. has seen significant growth in its business, driven by an increase in demand for genetic testing services among healthcare professionals and consumers. In 2020, the company reported over $339 million in revenue, an increase of 542% from the previous year.
Overall, Fulgent Genetics Inc. is one of the leading genetic testing companies in the US, offering a range of high-quality and affordable genetic testing services to its clients. With its commitment to innovation and technology, the company is well-positioned to continue growing in the years to come.
Company Address: 4399 Santa Anita Avenue El Monte 91731 CA
Company Phone Number: 350-0537 Stock Exchange / Ticker: NASDAQ FLGT
|
0.18% 
100.92 %